ACR DO NOT MISS - EMEUNET

EDITION OCTOBER 2018

ACR DO NOT MISS

ACR 2018 CHICAGO

ORAL PRESENTATIONS AND POSTERS

MENTOR/MENTEE MEETINGS

NETWORKING EVENT

ISSN 2521-7852

DIRECTORY

EDITORIAL

2

Dear young rheumatologists and researchers in rheumatology,

We are happy to present you a new issue of EMEUNEWS with a selection of not to be missed abstracts at this year´s ACR annual meeting.

The ACR congress is one of the largest scientific events in rheumatology. As this year’s congress is fast approaching, we provide you with a selection of oral presentations and posters that we consider to be noteworthy. This selection is a personal one by the contributors and cannot possibly hope to capture all of the exciting new research to be presented, however, we hope it provides an overview of some interesting sessions.

In addition, this Newsletter contains details about EMEUNET events organized during the Congress.

EMEUNET is active on social media channels, such as Facebook, Twitter and LinkedIn, in addition to our website and the dynamic physical presence in all major rheumatology events.

If this is your first contact with EMEUNET, we invite you to explore more, and join us. If you are already part of our community, we kindly remind you that sharing is caring. Spread the word about our activities and work, and help us reach more young rheumatologists and researchers.

We hope you enjoy reading this Newsletter. We always welcome feedback, comments, suggestions, and contributions.

We wish you a prolific and successful ACR 2018.

See you all in Chicago!

George Fragoullis and Antonis Fanouriakis, on behalf of the Newsletter Subgroup

OCTOBER 2018

More information about EMEUNET can be found at http://emeunet.eular.org

You can also reach us through the following email [email protected]

www.facebook.com/EMEUNET

www.twitter.com/EMEUNET

http://www.linkedin.com

ACR 2018: Oral presentations & posters 3

Basic Research I

Basic Research II

RA I

RA II

RA III

Psoriatic Arthritis

Axial Spondyloarthritis

SLE and APS

Other connective tissue diseases

Imaging

Osteoarthritis and Osteoporosis

Metabolic and Crystal Arthropathies

Paediatric Rheumatology

Rare and Autoinflammatory Diseases

3

4

5

6

7

8

9

10

11

12

13

14

15

16

MENTOR MENTEE MEETINGS 17

EMEUNET NETWORKING EVENT 18

EDUCATIONAL EVENTS 19

COURSES 21

EMEUNET CALENDAR 22

BE PART OF THE EMEUNET COMMUNITY 23

3

BASIC RESEARCH I (genetics, cartilage/synovium, osteoimmunology, animal models)

Stefano Alivernini

ORAL PRESENTATIONS & POSTERS ACR 2018 CHICAGO

OCTOBER 2018

Type, n° Date, time Session Room Author Title

Oral

849

Sunday

21.10.2018

14.30

3S085 ACR Abstract:

Osteoarthritis & Joint Biology–Basic Science

(846–850)

W194a Cheng Zhou

(USA)

CONSTRUCTING A MACROPHAGE INFILTRATION TIMELINE IN A MURINE

MODEL OF OSTEOARTHRITIS

Oral

928

Sunday

21.10.18

16.30

3S107 ACR Abstract: RA–

Etiology & Pathogenesis I

(928–933)

W190a Kevin Wei

(USA)

SINGLE CELL RNA-SEQUENCING OF RHEUMATOID SYNOVIAL FIBROBLASTS

REVEALS A DISEASE-ASSOCIATED SPATIAL GRADIENT MODULATED BY INDUCTIVE

NOTCH SIGNALING

Oral

930

Sunday

21.10.18

16.30

3S107 ACR Abstract: RA–

Etiology & Pathogenesis I

(928–933)

W190a Deepa Hammaker

(USA)

JOINT LOCATION-SPECIFIC IL6 AND JAK-STAT SIGNALING IN RHEUMATOID ARTHRITIS (RA) FIBROBLAST-LIKE

SYNOVIOCYTES (FLS)

Oral

1823

Monday

22.10.18

14:30

4M085 ACR Abstract: RA–Animal Models (1822–1827)

W474a Qi Quan Huang

(USA)

LOSS OF SYNOVIAL TISSUE RESIDENT MACROPHAGES PERMITS MONOCYTE TO

MACROPHAGE DIFFERENTIATION AND INFLAMMATION IN HUPO MICE

Poster

2058

Tuesday

23.10.18

9:00

Spondyloarthritis Including Psoriatic

Arthritis – Basic Science Poster

ACR Poster Session C

Fardina Malik

(USA)

EFFECTS OF FATTY ACID SUPPLEMENTATION IN MODULATION OF GUT MICROBIOME AND T-REGULATORY

CELLS IN HEALTH AND PSORIATIC DISEASE

Poster

2076

Tuesday

23.10.18

9:00




Kim Jeucken

(The Netherlands)

TRANSMEMBRANE TNF (TMTNF) TRANSGENIC MICE EXHIBIT ENLARGED

LYMPH NODES AND ELEVATED NUMBERS OF HIGH ENDOTHELIAL CELLS ASSOCIATED

WITH INCREASED LYMPHOCYTE RECRUITMENT

Poster

2060

Tuesday

23.10.18

9:00




Alessandra Nerviani

(UK)

COMPARATIVE HISTOLOGIC AND MOLECULAR ANALYSIS OF SYNOVIAL TISSUE IN EARLY TREATMENT-NAÏVE

PSORIATIC AND RHEUMATOID ARTHRITIS

Oral

2902

Wednesday

24.10.2018

9:00

6W009 ACR Abstract: RA–

Etiology & Pathogenesis II (2898 - 2903)

W184d Pooja Naik

(USA)

ANTIBODIES TO PAD4 DRIVE MONOCYTE ACTIVATION AND DIFFERENTIATION INTO

OSTEOCLAST-LIKE CELLS

Stefano is an academic researcher and consultant rheumatologist at the Fondazione Policlinico A. Gemelli IRCCS - Catholic University of The Sacred Heart (Rome). He got his PhD in Clinical Proteomics and his main areas of research are synovitis pathogenesis, epigenetics, and personalized medicine. Stefano is a member of the Country Liaison Subgroup.

4

BASIC RESEARCH II (immunity, immunology)

Felice Rivellese


OCTOBER 2018


Poster

151

Sunday

21.10.18

9:00

T Cell Biology and Targets in

Autoimmune and Inflammatory

Disease Poster

Poster Hall B Pavanish Kumar

(Singapore)

MOLECULAR MECHANISMS OF PATHOGENIC T CELL RESILIENCE IN HUMAN

ARTHRITIS

Poster

1014

Monday

22.10.18

9:00

Innate Immunity Posters

Poster Hall B Megan M. Hanlon

(Ireland)

DISTINCT MACROPHAGE PHENOTYPE AND BIOENERGETIC PROFILES IN RHEUMATOID

ARTHRITIS

Oral

2791

Tuesday

23.10.18

14.30

B Cell Biology and Targets in


Disease

W181c Alejandro Gomez

(USA)

CHARACTERIZATION OF MONOCLONAL ANTI-PAD4 AUTOANTIBODIES FROM RHEUMATOID ARTHRITIS PATIENTS:

FUNCTIONAL IMPLICATIONS FOR CITRULLINATION AND DISEASE

PROGRESSION

Oral

2793

Tuesday

23.10.18

15.00



Disease

W181c Natalia Sherina

(Sweden)

MOLECULAR MIMICRY AND AUTOIMMUNITY: ANTI-P. GINGIVALIS ANTIBODY RESPONSE

IN ACPA-POSITIVE RHEUMATOID ARTHRITIS

Oral

2795

Tuesday

23.10.18

15.30



Disease

W181c Huixian Hong

(USA)

IL-23 ACTS THROUGH IL-23R+ TFH CELLS TO PROMOTE PATHOGENIC IGG

AUTOANTIBODY FORMATION IN LUPUS

Oral

2801

Tuesday

23.10.18

15.30

T Cell Biology and Targets in


Disease

W474a

Kazuhiko Higashioka

(Japan)

A NOVEL B-CELL-HELPER IL-21-PRODUCING CD8+ T CELL SUBSET INVOLVED IN THE

PATHOGENESIS OF RHEUMATOID ARTHRITIS

Oral

2852

Tuesday

23.10.18

17.00

Innate Immunity W183c Laura van Dam

(the Netherlands)

EXCESSIVE FORMATION OF NEUTROPHIL EXTRACELLULAR TRAPS: DIFFERENT ROLE

IN THE PATHOGENESIS OF ANCA-ASSOCIATED VASCULITIS AND SYSTEMIC

LUPUS ERYTHEMATOSUS

Oral

2898

Wednesday

24.10.18

9.00

Rheumatoid Arthritis – Etiology and Pathogenesis

W184d Paula Fortea-Gordo

(Spain)

INCREASED FREQUENCY OF CIRCULATING CD4+CXCR5-PD1HI PERIPHERAL HELPER T

(CTPH) CELLS IN PATIENTS WITH SEROPOSITIVE EARLY RHEUMATOID

ARTHRITIS (RA)

Felice is a postdoctoral research fellow and clinical fellow at the Centre for Experimental Medicine and Rheumatology of Queen Mary University of London. His main research interest is on mast cells and the cross talk between innate and adaptive immunity in rheumatic diseases. Felice is a member of the Visibility Subgroup

5

RA I (epidemiology, clinics and non biologics)

Deshiré Alpízar-Rodríguez


OCTOBER 2018


Poster

202

Sunday

21.10.2018

9:00

Epidemiology and Public Health Poster I:Rheumatoid Arthritis

Poster

Hall B

Smolik I

(Canada)

RISK OF INFLAMMATORY ARTHRITIS DEVELOPMENT IN THE FAMILIY

MEMBERS OF INDIGENOUS NORTH AMERICAN (INA) RA PATIENTS

Poster

215

Sunday

21.10.2018

9:00

Epidemiology and Public Health Poster I:Rheumatoid Arthritis

Poster

Hall B

Chopra A

(India)

A DECADE EARLIER-ONSET OF SYMPTOMS OF RA IN THE INDIAN (ASIAN)

COHORT COMPARED TO DUTCH COHORT: BASED ON METEOR, A GLOBAL

DATABASE

Oral

835

Sunday

21.10.2018

11:00

3S037 ACR Abstract:Plenary

Session I (835-839) W375c

Musters A

(Netherlands)

IDENTIFYING INDIVIDUALS WITH HIGH RISK FOR INMINENT ONSET OF

RHEUMATOID ARTHRITIS

Oral

884

Sunday

21.10.2018

14:30

3S086 ACR Abstract: DX, Manifestations, & Outcomes I: Other Co-Morbidities (880-885)

W375a Sparks JA

(USA)

RHEUMATOID ARTHRITIS DISEASE ACTIVITY PREDICTING INCIDENT

CLINICALLY-APPARENT INTERSTITIAL LUNG DISEASE: A PROSPECTIVE

COHORT STUDY

Oral

1840

Monday 22.10.2018

14:30

4M083 ACR Abstract: Healthcare Disparities

in Rheumatology (1840-1845)

W471b Bergstra SA

(Netherlands)

DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS PATIENTS IS INFLUENCED BY

COUNTRIES’ SOCIOECONOMICS: RESULTS FROM THE METEOR REGISTRY

Oral

1863

Monday 22.10.2018

14:30

4M086 ACR Abstract:RA-DX, Manifestations, &

Outcomes II: DX & Prognosis I (1858-1863)

S100a Bettner LF

(USA)

ANTI-CYCLIC CITRULLINATED PROTEIN ANTIBODY AT MULTIPLE CUTOFF LEVELS

AND IN COMBINATION WITH RHEUMATOID FACTOR IGM AND SERUM

CALPROTECTIN IS HIGHLY SPECIFIC FOR THE DEVELOPMENT OF RHEUMATOID

ARTHRITIS WITHIN 3 YEARS

Oral

1853

Monday

22.10.2018

14:30

4M087 ACR Abstract: Reproductive Issues in Rheumatic Distorders

(1852-1857)

W183c Bo Jensen T

(Denmark)

PATERNAL USE OF METHOTREXATE (MTX) AND CONGENITAL

MALFORMATIONS- A SYSTEMATIC REVIEW AND META-ANALYSIS

Poster

2488

Tuesday

23.10.2018

9:00

Rheumatoid Arthritis-Diagnosis,

Manifestations, and Outcomes Poster III:

Complications of Therapy, Outcomes,

and Measures

Poster

Hall B

Roodenrijs NMT

(Netherlands)

CHARACTERISTICS OF DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS: RESULTS OF AN INTERNATIONAL

SURVEY

Deshiré is an internal medicine physician and rheumatologist. She got a MD-PhD in clinical research at the University of Geneva, Switzerland and her major research interests include female reproductive factors and rheumatic diseases, particularly rheumatoid arthritis and systemic lupus erythematosus. Deshire is a member of the Social Media Subgroup.

6

RA II (biological therapies: anti-TNF)

Sebastián C Rodriguez-García


OCTOBER 2018


Poster

622

Sunday

21.10.18

9:00

Rheumatoid Arthritis – Treatments Poster I:

Strategy and Epidemiology

Poster Hall B

Pope J (Canada)

DMARD WITHDRAWAL IN RA PATIENTS ACHIEVING THERAPEUTIC RESPONSE WITH

CERTOLIZUMAB PEGOL COMBINED WITH DMARDS: RESULTS FROM A CANADIAN

RANDOMIZED STUDY

Oral

961

Sunday

21.10.18

16:30

3S108 ACR Abstract: RA–Treatments II: Safety

(958–963) W375a Jani M

(UK)

THE ASSOCIATION OF BIOLOGIC DRUG-LEVELS WITH INFECTION RISK: RESULTS

FROM THE BRITISH SOCIETY FOR RHEUMATOLOGY BIOLOGICS REGISTER

FOR RHEUMATOID ARTHRITIS

Poster

1553

Monday

22.10.18

9:00

Rheumatoid Arthritis – Treatments Poster II:

PROs, Safety and Comorbidity

Poster

Hall B

Edwards CJ (UK)

AN ANALYSIS OF REAL-WORLD DATA ON THE SAFETY OF ETANERCEPT IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS

Poster

2514

Tuesday

23.10.18

9:00

Rheumatoid Arthritis – Treatments Poster III: Biosimilars and New

Compounds

Poster

Hall B

Yoo D (Korea)

DEVELOPMENT OF A SUBCUTANEOUS FORMULATION OF CT-P13 (INFLIXIMAB):

MAINTENANCE SUBCUTANEOUS ADMINISTRATION MAY ELICIT LOWER

IMMUNOGENICITY COMPARED TO INTRAVENOUS TREATMENT

Oral

2820

Tuesday

23.10.18

14:30

5T089 ACR Abstract: RA–Treatments IV: Strategy

(2820–2825) W185a

Tanaka Y (Japan)

SUSTAINED CLINICAL REMISSION AFTER DISCONTINUATION OF INFLIXIMAB WITH A

RAISING DOSE STRATEGY IN PATIENTS WITH RHEUMATOID ARTHRITIS (RRRR STUDY): A

RANDOMIZED CONTROLLED TRIAL

Oral

2823

Tuesday

23.10.18

14:30

5T089 ACR Abstract: RA–Treatments IV: Strategy

(2820–2825) W185a

Santos Faria D (Portugal)

COMPARATIVE LONG-TERM EFFECTIVENESS OF SWITCHING TO ANOTHER TUMOUR

NECROSIS FACTOR ANTAGONISTS, TOCILIZUMAB OR RITUXIMAB IN PATIENTS

WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO A FIRST-LINE

TNF INHIBITOR

Oral

2877

Tuesday

23.10.18

16:30

5T109 ACR Abstract: RA–Treatments V: Beyond Individual

Compounds (2874–2879)

S100a Pappas D

(US)

THE COMPARATIVE EFFECTIVENESS OF FIRST-LINE TUMOR NECROSIS FACTOR

INHIBITOR (TNFI) COMPARED WITH NON-TNFI AGENTS IN PATIENTS WITH RHEUMATOID

ARTHRITIS: RESULTS FROM THE CORRONA REGISTRY

Oral

2879

Tuesday

23.10.18

16:30

5T109 ACR Abstract: RA–Treatments V: Beyond Individual

Compounds (2874–2879)

S100a Fanning N

(New Zealand)

PLASMA IL-23 AND IL-25 PREDICT RESPONSE TO ANTI-TNF-Α THERAPY IN RHEUMATOID

ARTHRITIS

Sebastián is a rheumatology fellow at the Hospital Clínic of Barcelona. His research interests include pharmacoepidemiology and rheumatoid arthritis. He is currently pursuing a master’s degree in Epidemiology at the Autonomous University of Barcelona and is now a member of the peer-mentoring subgroup.

7

RA III Other biologics and new drugs beyond biologics

Kim Lauper


OCTOBER 2018


Poster

557

Sunday

21.10.2018

9:00

Rheumatoid Arthritis –

Treatments Poster I: Strategy and Epidemiology

Poster

Hall B

Finckh A (Switzerland)

THE IMPACT OF COMEDICATION WITH CONVENTIONAL SYNTHETIC DMARDS ON DRUG RETENTION AND CLINICAL

EFFECTIVENESS OF TOFACITINIB, ANTI–TUMOR NECROSIS FACTOR THERAPY

AND BIOLOGICS WITH AN ALTERNATIVE MODE OF ACTION IN PATIENTS WITH RHEUMATOID ARTHRITIS. A COHORT

STUDY

Oral

887

Sunday

21.10.2018

14:45

Rheumatoid arthritis –

Treatments I: JAK Inhibitors

S100a Tanaka Y (Japan)

EFFICACY AND SAFETY OF THE NOVEL ORAL JANUS KINASE (JAK) INHIBITOR, PEFICITINIB (ASP015K), IN A PHASE 3,

DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY OF

PATIENTS WITH RA WHO HAD AN INADEQUATE RESPONSE TO DMARDS

Oral

958

Sunday

21.10.2018

16:30


Treatments II:Safety

W375a Curtis JR

(USA)

TOCILIZUMAB AND THE RISK FOR CARDIOVASCULAR DISEASE EVENTS

AMONG RHEUMATOID ARTHRITIS PATIENTS: A DIRECT COMPARISON IN

REAL WORLD SETTING

Oral

960

Sunday

21.10.2018

17:00


Treatments II:Safety

W375a Barbulescu A

(Sweden)

THE RISK OF GASTROINTESTINAL PERFORATIONS ASSOCIATED WITH

BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS USED IN RHEUMATOID ARTHRITIS: A

NATIONWIDE SWEDISH COHORT STUDY

Poster

1518

Monday

22.10.2018

9:00

Rheumatoid Arthritis –

Treatments Poster II: PROs,

Safety and Comorbidity

Poster

Hall B

Meißner Y (Germany)

BARICITINIB AND TOFACITINIB IN REAL LIFE – DOES OBESITY IMPACT RESPONSE TO JANUS KINASE

INHIBITOR THERAPY IN RHEUMATOID ARTHRITIS?

Oral

1935

Monday

22.10.2018

16:30


Treatments III: New Compounds

& Biosimilars

S100bc Huang J (USA)

MULTIPLE DOSE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND

PHARMACODYNAMICS OF ASP5094, AN ANTI-ALPHA9 INTEGRIN MONOCLONAL

ANTIBODY, IN PATIENTS WITH RHEUMATOID ARTHRITIS ON

METHOTREXATE

Kim is a rheumatologist fellow at the Geneva University Hospital, Switzerland and PhD student at the University of Manchester under the supervision of Prof. Kimme Hyrich. Her research focuses on rheumatoid arthritis and epidemiology, particularly on comorbidities, methodological issues, drug effectiveness and adverse events in real-world data. Kim is a member of the Peer-mentoring Subgroup

8

PSORIATIC ARTHRITIS

James Bluett


OCTOBER 2018


Poster

684

Sunday

21.10.18

09:00

Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Imaging, Clinical Studies, and Treatment

Poster

Hall B

Frank Behrens (Germany)

EFFICACY OF IXEKIZUMAB IN DIFFERENT PHENOTYPES OF PATIENTS WITH ACTIVE

PSORIATIC ARTHRITIS (PSA): RESULTS FROM THE SPIRIT TRIALS

Oral

965

Sunday

21.10.18

16:30

Spondyloarthritis Including PsA–Clinical II: PsA Epidemiology

S100a Clémence Gorlier

(France)

DEFINING CUTOFFS CORRESPONDING TO LOW LEVELS OF DISEASE ACTIVITY IN

PSORIATIC ARTHRITIS, USING THE PATIENT-REPORTED PSORIATIC ARTHRITIS IMPACT OF DISEASE

QUESTIONNAIRE (PSAID12). AN ANALYSIS OF 436 PATIENTS

Poster

1598

Monday

22.10.18

09:00

Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Clinical/

Epidemiology Studies

Poster

Hall B

Antonio Wong Lam

(Canada)

DEPRESSION AND ANXIETY REDUCE PROBABILITY OF ACHIEVING A STATE OF MINIMAL DISEASE ACTIVITY IN PATIENTS

WITH PSORIATIC ARTHRITIS

Poster

1604

Monday

22.10.18

09:00

Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Clinical/

Epidemiology Studies

Poster

Hall B

Kim Wervers (Netherlands)

IMPACT OF TIME TO MINIMAL DISEASE ACTIVITY AND QUALITY OF LIFE ONE

YEAR AFTER DIAGNOSIS OF PSORIATIC ARTHRITIS

Oral

2787

Tuesday

23.10.18

11:00

Plenary Session III W375c Vinod Chandran

(Canada)

−21 HLA-CLASS I DIMORPHISM DIFFERENTIATES PSORIATIC ARTHRITIS

(PSA) FROM PSORIASIS WITHOUT PSORIATIC ARTHRITIS (PSC)

Oral

2886

Tuesday

23.10.18

16:30

Spondyloarthritis Including PsA–Clinical V: Tx of

PsA & Peripheral SpA

S100bc Laura Coates

(United Kingdom)

SECUKINUMAB PROVIDES RAPID AND SUSTAINED RESOLUTION OF ENTHESITIS

IN PSORIATIC ARTHRITIS PATIENTS: POOLED ANALYSIS OF TWO PHASE 3

STUDIES

James is a senior clinical lecturer, honorary consultant in rheumatology and co-deputy director of the MSc “Clinical rheumatology” at the University of Manchester, UK, with an interest in strategies to improve treatment response in rheumatoid arthritis. In 2015, He completed a PhD investigating methotrexate adherence in rheumatoid arthritis and methotrexate-pneumonitis. James is a member of the Newsletter Subgroup.


9

AXIAL SPONDYLOARTHRITIS

Maddalena Larosa

OCTOBER 2018


Poster

670

Sunday

21.10.2018

09:00

Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Imaging,

Clinical Studies, and Treatment

Poster

Hall B

Braun J

(Germany)

LOW RATE OF SPINAL RADIOGRAPHIC PROGRESSION OVER 2 YEARS IN

ANKYLOSING SPONDYLITIS PATIENTS TREATED WITH SECUKINUMAB: A HISTORICAL

COHORT COMPARISON

Poster

638

Sunday

21.10.2018

09:00

Spondyloarthritis Including Psoriatic Arthritis – Clinical: Imaging, Clinical

Studies, and Treatment

Poster

Hall B

Gossec L

(France)

DIAGNOSTIC DELAY AND ASSOCIATED FACTORS IN AXIAL SPONDYLOARTHRITIS ACROSS EUROPE. RESULTS FROM THE

EUROPEAN MAP OF AXIAL SPONDYLOARTHRITIS SURVEY

Poster

639

Sunday

21.10.2018

09:00



Poster

Hall B

Couvaras L (France)

IS A PRIMARY GOOD RESPONSE TO NSAIDS PREDICTIVE OF THE SUBSEQUENT

RESPONSE TO THE FIRST TNF INHIBITOR IN PATIENTS WITH EARLY AXIAL

SPONDYLOARTHRITIS ?

Poster

651

Sunday

21.10.2018

09:00



Poster

Hall B

Baraliakos X (Germany)

ANALYSIS OF THE DIFFERENT VALUE OF MAGNETIC RESONANCE IMAGING CHANGES

IN THE SACROILIAC JOINTS FOR A DIAGNOSIS OF AXIAL SPONDYLOARTHRITIS AS JUDGED BY RHEUMATOLOGISTS AND RADIOLOGISTS

Oral

968

Sunday

21.10.2018

17:30

ACR Abstract: Spondyloarthritis

Including PsA–Clinical II: PsA Epidemiology

(964–969)

S100a Maksymowych WP (Canada)

WHAT IS THE IMPACT OF IMAGING ON DIAGNOSTIC ASCERTAINMENT OF PATIENTS

PRESENTING WITH UNDIAGNOSED BACK PAIN IN ROUTINE PRACTICE AND THE IMPACT OF

CENTRAL READING? DATA FROM THE SCREENING IN AXIAL SPONDYLOARTHRITIS IN

PSORIASIS, IRITIS, AND COLITIS COHORT

Oral

2887

Tuesday

23.10.2018

16:45

Spondyloarthritis Including PsA–Clinical

V: Tx of PsA & Peripheral SpA (2886–2891)

S100bc Mogard E

(Sweden)

CHRONIC PAIN AND ASSESSMENT OF PAIN SENSITIVITY IN PATIENTS WITH ESTABLISHED

AXIAL SPONDYLOARTHRITIS – A CROSS-SECTIONAL STUDY

Oral

2891

Tuesday

23.10.2018

17:45


Including PsA–Clinical V: Tx of PsA & Peripheral SpA (2886–2891)

S100bc Marona J

(Portugal)

ELIGIBILITY CRITERIA FOR TNFI THERAPY IN AXIAL SPA: GOING BEYOND BASDAI

Oral

2924

Wednesday

24.10.2018

09:30


Including PsA–Clinical VI: Imaging of Axial SpA (2922–2927)

W183a Ramiro S

(Netherlands)

SPINAL RADIOGRAPHIC PROGRESSION IN EARLY AXIAL SPONDYLOARTHRITIS: 5-YEAR

DATA FROM THE DESIR COHORT

Maddalena is a rheumatology resident at the Division of Rheumatology, Department of Medicine-DIMED at University of Padova, Italy. She is due to complete her training rheumatology fellowship in December 2018. Her research interests include systemic lupus erythematosus, connective tissue diseases, pregnancy and rheumatic diseases and antiphospholipid syndrome. Maddalena is a member of the Education and Country Liaisons Subgroups.

10

SLE & APS

Chris Wincup


OCTOBER 2018


Oral

851

Sunday

21.10.2018

14.30

3S079 ACR Abstract:

Antiphospholipid Syndrome

W183c Gautam Sule

(USA)

INTERGRIN MAC-1 POTENTIATES NEUTROPHIL ADHESION AND NET RELEASE IN ANTIPHOSPHOLIPID

SYNDROME

Oral

970

Sunday

21.10.2018

16.30

3S110 ACR Abstract: SLE -

Clinical I: Clinical Trials

S100bc Daniel J Wallace

(USA)

BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS:

RESULTS FROM A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-

CONTROLLED STUDY

Poster

1090

Monday

22.10.2018

9.00

Systemic lupus erythematosus -

Etiology and Pathogenesis

Poster II

Poster

Hall B

Bhargavi Duvvuri

(USA)

CELL-FREE MITOCHONDRIAL DNA AS A NOVEL BIOMARKER IN SYSTEMIC LUPUS

ERYTHEMATOSUS

Oral

1941

Monday

22.10.2018

16.30

4M107 ACR Abstract: SLE -

Clinical II: Renal & Neuropsychiatric Disease in SLE

W375a

Michelle Barraclough

(UK)

ALTERED COGNITIVE FUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS AND

ASSOCIATIONS WITH INFLAMMATION AND FUNCTIONAL BRAIN CHANGES

Poster

2118

Tuesday

23.10.2018

9.00

Systemic lupus erythematosus -

Etiology and Pathogenesis

Poster III

Poster

Hall B

Giuseppe Alvise Ramirez

(Italy)

PREVALENCE OF ACQUIRED ACTIVATED PROTEIN C RESITANCE AND ANTI-

PROTEIN C ANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS

Oral

2833

Tuesday

23.10.2018

14.30

5T090 ACR AbstractL SLE -

Clinical III: Translational

Aspects

W196b

Rosalind Ramsey-Goldman

(USA)

COMPLEMENT ACTIVATION IS A FEATURE OF DISEASES IN THE LUPUS SPECTRUM

Oral

2947

Wednesday

24.10.2018

11.00

6W024 ACR Abstract: SLE -

Etiology & Pathogenesis II

W184d Ayako Makiyama

(Japan)

PERIPHERAL HELPER T CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS

Chris is an Arthritis Research UK funded Clinical Research Fellow undertaking a PhD in the Department of Rheumatology at University College London, UK. His work primarily focuses on investigating the role of altered iron homeostasis and mitochondrial dysfunction in SLE. Chris is a member of the Social Media subgroup.

11

OTHER CONNECTIVE TISSUE DISEASES Including systemic sclerosis, myositis, vasculitis

Blaž Burja


OCTOBER 2018


Poster

118

Sunday

21.10.2018

9:00

Systemic Sclerosis and Related

Disorders – Basic Science Poster I,

ACR Poster Session A

Poster

Hall B

Swati Bhattacharyya

(USA)

PHARMACOLOGICAL INHIBITION OF JAK/STAT SIGNALING BY TOFACITINIB

PREVENTS EXPERIMENTAL ORGAN FIBROSIS: NOVEL THERAPY FOR

SYSTEMIC SCLEROSIS

Oral

899

Sunday

21.10.2018

2:30

3S089 ACR Abstract: Systemic Sclerosis &

Rel D/O–Clinical I: Clinical Trials I (898–

903)

W178b Shervin Assassi

(USA)

CHANGES IN THE SYSTEMIC SCLEROSIS MOLECULAR SIGNATURES AFTER MYELOABLATION FOLLOWED BY

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION AND THEIR

CLINICAL CORRELATES

Poster

827

Sunday

21.10.2018

9:00

Vasculitis Poster I: Non-ANCA-

Associated and Related Disorders,

ACR Poster Session A

Poster

Hall B

Caitrin Coffey (USA)

RITUXIMAB THERAPY FOR SYSTEMIC RHEUMATOID VASCULITIS: INDICATIONS,

OUTCOMES AND ADVERSE EVENTS

Oral

1879

Monday

22.10.2018

14:30

4M090 ACR Abstract: Systemic Sclerosis & Rel D/O–Clinical II:

Clinical Trials II (1875–1880)

W190a Dinesh Khanna

(USA)

THE EFFECTS OF RIOCIGUAT ON RAYNAUD’S PHENOMENON AND DIGITAL

ULCERS IN PATIENTS WITH DIFFUSE SYSTEMIC SCLEROSIS: RESULTS FROM

THE PHASE IIB RISE-SSC STUDY

Oral

1904

Monday

22.10.2018

16:30

4M109 ACR Abstract: Systemic Sclerosis &

Rel D/Os–Basic Science (1899–1904)

W474a Ruifang Liang

(Germany)

ORPHAN NUCLEAR RECEPTOR RORΑ IS A KEY REGULATOR OF TGFΒ- AND WNT-

SIGNALING IN FIBROTIC DISEASES

Oral

2842

Tuesday

23.10.2018

14:30

5T093 ACR Abstract: Vasculitis–Non-

ANCA-Assocd & Rel D/Os II: Novel

Diagnostics & THRs (2838–2843)

W470b Alojzija Hočevar

(Slovenia) DOES LEFLUNOMIDE HAVE A ROLE IN

GIANT CELL ARTERITIS?

Oral

2977

Wednesday

24.10.2018

11:0

6W022 ACR Abstract: Muscle Biology,

Myositis & Myopathies II:

Clinical & Misc Topics (2976–2981)

W185a Victoria P. Werth

(USA)

LENABASUM, A CANNABINOID TYPE 2 RECEPTOR AGONIST, REDUCES T-CELL

POPULATION AND DOWNREGULATES TYPE 1 AND 2 INTERFERON ACTIVITIES IN

LESIONAL DERMATOMYOSITIS SKIN

Blaž is a PhD student at Department of Rheumatology, University Medical Centre Ljubljana, Slovenia. His major research focus is on systemic sclerosis (SSc), with a particular interest in metabolic and epigenetic dysregulation. Blaž is a member of the Peer-mentoring subgroup.

12

IMAGING


OCTOBER 2018


Poster

303

Sunday

21.10.18

9:00

Imaging of Rheumatic

Diseases Poster I: MRI

Poster

Hall B

Philipp Sewerin (Germany)

THE VALUE OF THE SIMPLIFIED RAMRIS-5 IN EARLY RA PATIENTS UNDER

METHOTREXATE THERAPY USING HIGH FIELD MRI

Poster

668

Sunday

21.10.18

9:00

Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Imaging,

Clinical Studies, and Treatment

Poster

Hall B

Jou Feld

(Canada)

PROGRESSION OF UNILATERAL GRADE 2 SACROILIITIS IN A PSORIATIC ARTHRITIS

COHORT

Poster

318

Sunday

21.10.18

9:00


Diseases Poster I: MRI

Poster

Hall B

Martin Fruth

(Germany)

INFLAMMATORY FINDINGS DETECTED BY MRI AT ENTHESEAL SITES IN THE PELVIC

GIRDLE OF PATIENTS WITH POLYMYALGIA RHEUMATICA HAVE POTENTIAL FOR A

DIAGNOSTIC TEST

Poster

863

Sunday

21.10.18

14:30


Diseases I: MRI & CT

W190a Nobuya Abe

(Japan)

COMBINING CARDIAC MAGNETIC RESONANCE AND RIGHT HEART

CATHETERIZATION TO EVALUATE RIGHT VENTRICULAR FUNCTION FOR THE

PROGNOSIS PREDICTION IN PATIENTS WITH CONNECTIVE TISSUE DISEASES AND

PULMONARY HYPERTENSION

Poster 1210

Monday

22.10.18

09:00


Diseases Poster II: Ultrasound

Poster

Hall B

Kristofoor Leeuwenberg

(USA)

SONOGRAPHIC APPEARANCE OF INFLAMMATORY MYOPATHIES: INCREASED

MUSCLE ECHOINTENSITY AND QUALITATIVE CHANGES

Poster 1200

Monday

22.10.18

9:00


Diseases Poster II: Ultrasound

Poster

Hall B

Lene Terslev

(Denmark)

UNILATERAL ULTRASOUND SCORING METHODS FOR SYNOVITIS IN RHEUMATOID

ARTHRITIS: AN AGREEMENT STUDY EXPLORING THE MOST INFLAMMATORY

ACTIVE SIDE

Poster 2197

Tuesday

23.10.18

9:00


Diseases Poster III: Other Modalities

Poster

Hall B

Paula Estrada

(Spain)

STEROID BOLUS LEADS TO A NEGATIVE 18F-FDG PET/CT SCAN IN LARGE VESSEL

VASCULITIS. DATA FROM A MULTICENTER GIANT CELL ARTERITIS COHORT DATABASE

Oral

2924

Wednesday 24.10.18

09:00

6W011 ACR Abstract:

Spondyloarthritis Including PsA–

Clinical VI: Imaging of Axial SpA

W183a Sofia Ramiro

(Netherlands)

SPINAL RADIOGRAPHIC PROGRESSION IN EARLY AXIAL SPONDYLOARTHRITIS: 5-YEAR

DATA FROM THE DESIR COHORT

Peter is a board-certified rheumatologist and attending physician at University Medical Center Göttingen, Germany. His research focuses on systemic autoimmune diseases, primarily systemic lupus erythematosus, systemic sclerosis, sarcoidosis and inflammatory myositis. He has a special interest on the effect of these diseases on major organs and their epidemiology. He has been working as a junior methodologist for a European Respiratory Society Task Force on Sarcoidosis Treatment. Peter is a member of the Education Subgroup.

Peter Korsten

13

OSTEOARTHRITIS AND OSTEOPOROSIS

Achilleas Floudas


OCTOBER 2018


Poster

426

Sunday

21.10.2018

09:00

Osteroarthritis clinical Poster 1

Poster

Hall B

Shuang Zheng

(Australia)

THE ASSOCIATION OF DIETARY PATTERNS WITH KNEE SYMPTOMS AND

MRI DETECTED STRUCTURES IN PATIENTS WITH KNEE OSTEOARTHRITIS

(OA)

Poster

437

Sunday

21.10.2018

09:00

Osteroarthritis clinical Poster 1

Poster

Hall B

Dennis Ang

(USA)

DOES REDUCTION IN MECHANICAL KNEE JOINT LOADING EXPLAIN THE

BENEFICIAL EFFECTS OF WEIGHT LOSS IN OVERWEIGHT OR OBESE PATIENTS

WITH KNEE OSTEOARTHRITIS?

Oral

846

Sunday

21.10.2018

14:30


W194a Cheng Zhou

(USA)

CD14 DEFICIENCY DAMPENS OSTEOCLASTOGENESIS AND ALTERS

BONE REMODELING IN A MURINE MODEL OF OSTEOARTHRITIS

Oral

848

Sunday

21.10.2018

14:30


W194a Carmen Corciulo

(USA)

A2A ADENOSINE RECEPTOR STIMULATION SWITCHES TGF-Β

SIGNALING TO PROMOTE CHONDROCYTE PROLIFERATION AND

CARTILAGE REGENERATION

Oral

952

Sunday

21.10.2018

16:30

Osteoarthritis–Clinical W471b

Julie Davis

(USA)

EFFUSION-SYNOVITIS AND INFRAPATELLAR FAT PAD EDEMA

DIFFERENTIATE ACCELERATED KNEE OSTEOARTHRITIS: DATA FROM THE

OSTEOARTHRITIS INITIATIVE

Poster

1046

Monday

22.10.2018

09:00

Osteoarthritis and Joint Biology – Basic Science

Poster I

Poster

Hall B

Li Wang

(China)

DISTINCT BALANCE OF TNF-Α/IL-10 IN CIRCULATING AND INFILTRATING CD163+ MACROPHAGES BETWEEN RAPIDLY AND SLOWLY PROGRESSIVE SYMPTOMATIC

KNEE OSTEOARTHRITIS

Poster

2000

Tuesday

23.10.2018

09:00

Osteoarthritis and Joint Biology – Basic Science

Poster II

Poster

Hall B

Raewyn Poulsen

(New Zealand)

INTERLEUKIN-1Β, OXIDATIVE STRESS AND BASIC CALCIUM PHOSPHATE

CRYSTALS INDUCE OSTEOARTHRITIS-LIKE CHANGES IN CHONDROCYTE

PHENOTYPE BY ALTERING THE EXPRESSION OF PERIOD2, A CORE

COMPONENT OF THE CHONDROCYTE CIRCADIAN CLOCK

Poster

2309

Tuesday

23.10.2018

09:00

Osteoporosis and Metabolic

Bone Disease – Basic and

Clinical Science Poster

Poster

Hall B Karla Miller

(USA)

IMPLEMENTATION OF A PRIMARY PREVENTION, POPULATION-BASED VIRTUAL OSTEOPOROSIS CLINIC DRAMATICALLY INCREASES THE NUMBER OF RURAL VETERANS

RECEIVING OSTEOPOROSIS SCREENING AND TREATMENT

Achilleas completed his PhD at Newcastle University, UK, was then an Irish research fellow for the translational immunology lab of Trinity College Dublin, until he joined the Molecular Rheumatology group of Prof. Ursula Fearon. His research focuses on the role of B and T cells in the pathogenesis of RA, using advanced flow cytometric analysis techniques. Achilleas is a member of the Newsletter subgroup.

14

METABOLIC AND CRYSTAL ARTHROPATHIES

Gonçalo Boleto


OCTOBER 18


Oral

869

Sunday

21.10.2018

14:30

ACR Concurrent Abstract session:

Metabolic and Crystal Arthropathies -

Comorbidities and Outcomes

W185a Perez-Ruiz, F

(Spain)

FAILURE TO REACH SERUM URATE TARGET IS ASSOCIATED WITH

ELEVATED MORTALITY IN GOUT

Poster

1289

Monday

22.10.2018

09:00

ACR Poster session B: Metabolic and

Crystal Arthropathies -Basic and Clinical science Poster I

Milgroom, A (USA)

IMMUNOSUPRESSANT USE AND GOUT IN THE PREVALENT SOLID

ORGAN TRANSPLANT POPULATION

Poster

2225

Tuesday

23.10.2018

09:00

ACR Poster session C: Metabolic and

Crystal Arthropathies: -Basic and Clinical science Poster II

Corkill, M (New Zealand)

EXPLORING THE RELATIONSHIP BETWEEN GOUT AND DIFFUSE

IDIOPATHIC SKELETAL HYPEROSTOSIS (DISH): AN

EPIDEMIOLOGIC AND GENETIC STUDY

Poster

2251

Tuesday

23.10.2018

09:00

ACR Poster session C: Metabolic and

Crystal Arthropathies - Basic and Clinical science Poster II

Darrieutor-Laffite, C (France)

CALCIFIC TENDONITIS OF THE ROTATOR CUFF: DO WE NEED

STEROID INJECTION AFTER ULTRASOUND GUIDED

PERCUTANEOUS LAVAGE? RESULTS OF A 12-MONTHS DOUBLE-BLIND

RANDOMIZED CONTROLLED STUDY

Oral

2966

Wednesday

24.10.2018

11:00


Metabolic and Crystal Arthropathies – Basic science and Imaging

W178b Hammer, BH

(Norway)

ULTRASOUND SHOWS RAPID REDUCTION OF URIC LOAD DURING

TREAT-TO-TARGET APPROACH IN GOUT PATIENTS: RESULTS FROM A

LONGITUDINAL STUDY

Oral

2969

Wednesday

24.10.2018

11:00


Metabolic and Crystal Arthropathies – Basic science and Imaging

W178b Dalbeth, N

(New Zealand)

ALLOPURINOL DOSE ESCALATION SLOWS PROGRESSION OF CT BONE

EROSION IN PEOPLE WITH GOUT: IMAGING SUB-STUDY OF A

RANDOMIZED CONTROL TRIAL

Gonçalo is a trainee in rheumatology and clinical immunology in Reims University Hospital, France. His research focuses on the safety of biologics in rheumatoid arthritis and the pathophysiology of systemic sclerosis with a specific interest in experimental inflammationdriven fibrosis. Gonçalo is a member of the Newsletter Subgroup.

15

PAEDIATRIC RHEUMATOLOGY

Diederik De Cock


OCTOBER 2018


Oral

978

Sunday

21.10.18

16:30

3S115 ACR/ARHP Abstract: Pediatric Rheum (976–981)

W178b Horneff G (Germany)

TREAT-TO-TARGET STUDY FOR IMPROVED OUTCOME IN POLYARTICULAR

JUVENILE IDIOPATHIC ARTHRITIS

Oral

1848

Monday

22.10.18

14:30

4M084 ACR Abstract: Pediatric Rheum–Clinical I:

Outcomes & Comorbidities (1846–1851)

W196b Arias de la Rosa I

(Spain)

CARDIOVASCULAR RISK FACTORS IN ADULTS WITH JUVENILE IDIOPATHIC

ARTHRITIS IN SUSTAINED REMISSION

Oral

1849

Monday

22.10.18

14:30

4M084 ACR Abstract: Pediatric Rheum–Clinical I:

Outcomes & Comorbidities (1846–1851)

W196b Glerup M (Norway)

REMISSION STATUS AFTER 18 YEARS OF FOLLOW-UP IN THE POPULATION-BASED NORDIC JUVENILE IDIOPATHIC ARTHRITIS

(JIA) COHORT

Poster

2393

Tuesday

23.10.2018

9:00

Pediatric Rheumatology – Clinical Poster III: Juvenile Idiopathic

Arthritis and Uveitis

Kyvsgaard, N (Denmark)

IS METHOTREXATE-INDUCED NAUSEA IN JUVENILE IDIOPATHIC ARTHRITIS

INFLUENCED BY ANXIETY OR COPING STRATEGIES?

Oral

2866

Tuesday

23.10.2018

16:30

5T107 ACR Abstract: Pediatric Rheum–Clinical II: Treatment Update

(2862–2867)

W178b Heaf, E (UK)

BIOLOGIC REFRACTORY DISEASE IN A COHORT STUDY OF CHILDREN AND

YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS FROM THE UNITED

KINGDOM

Oral

2918

Wednesday

24.10.2018

9:00

6W008 ACR Abstract: Pediatric Rheum–Clinical III: Assessment Tools

& Biomarkers (2916–2921)

W183c Tucker L (Canada)

PHYSICAL ACTIVITY IN CANADIAN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: THE LEAP STUDY (LINKING

EXERCISE, ACTIVITY, AND PATHOPHYSIOLOGY IN CANADIAN

CHILDREN WITH ARTHRITIS)

Diederik is an epidemiologist working either in Manchester, UK or Leuven, Belgium. Aside from his full time job of being a father and professional sport enthusiast, he is analyzing investigator-initiated trials in early rheumatoid arthritis, investigating unmet needs for patients with early rheumatoid arthritisand analyzing the safety of biologic treatment in established rheumatoid arthritis and juvenile idiopathic arthritis. Diederik is the co-leader of the Social Media Subgroup.

16

RARE AND AUTOINFLAMMATORY DISEASES

Katja Lakota


OCTOBER 2018


Poster

370

Sunday

21.10.18

9:00

Miscellaneous Rheumatic and Inflammatory

Diseases Poster I

Poster

Hall B

Boyeva V. (Canada)

RITUXIMAB IN IDIOPATHIC RETROPERITONEAL FIBROSIS

Poster

371

Sunday

21.10.18

9:00


Diseases Poster I

Poster

Hall B

Zhang P.

(China)

THERAPEUTIC EFFICACY AND SAFETY OF IGURATIMOD IN TREATING MILD IgG4-

RELATED DISEASE

Poster

1026

Monday

22.10.18

9:00

Innate Immunity Poster

Poster

Hall B

Marrero B.

(USA)

AUTOINFLAMMATORY DISEASES, PARTICULARLY SAVI AND CANDLE, ARE

DRIVEN BY CHRONICALLY ACTIVE TYPE I INTERFERONS

Poster

2012

Tuesday

23.10.18

9:00

Pediatric Rheumatology- basic Science

Poster

Tsuji S.

(Japan)

THE NOVEL G58V MUTATION IN THE TNFRSF1A GENE IDENTIFIED IN A FAMILY

WITH TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC

SYNDROME (TRAPS) DECREASES CELL SURFACE EXPRESSION OF TNFR1

Poster

2276

Tuesday

23.10.18

9:00


Diseases Poster III

Poster

Hall B

Hoffmann P.

(USA)

RISK OF HEMORRAHAGIC STROKES IN PATIENTS WITH ADENOSINE DEAMINASE

2 DEFICINECY

Poster

2279

Tuesday

23.10.18

9:00


Diseases Poster III

Poster

Hall B

Yao Q.

(USA)

THERAPEUTIOC VALUE OF CANAKINUMAB IN PATIENTS WITH YAO

SYNDROME

Oral

2854

Tuesday

23.10.18

17:30

5T1054 ACR Abstract: Innate

immunity (2850-2855)

W183c Bhuyan F.

(USA)

MAJEED SYNDROME CAUSING LPIN2 MUTATIONS MAY PREVENT BONE

“HEALING” BY RENDERING M2 MACROPHAGE PROINFLAMMATORY

Katja Lakota, PhD, holds postdoctoral position in Immunology Laboratory, University Medical Centre Ljubljana, Slovenia and Assistant professor at FAMNIT, University of Primorska. Her main research interest are acute phase response in rheumatic diseases and fibrosis development in systemic sclerosis. Katja is a member of the Education subgroup.

Would you like the opportunity to discuss your research and future career with a leader in the field in a friendly and informal way? As every year, the EMEUNET Peer Mentoring subgroup is organizing the Mentor-Mentee meetings: do not miss the opportunity to sign up!

These meetings will be held on Tuesday, October 23th from 13:00h to 14:00h. The meeting place (inside the congress venue) will be announced in due time.

Currently, one mentor has confirmed his participation in the upcoming edition and the call for applications will be soon launched:

MENTOR MENTEE MEETINGS

OCTOBER 2018

MENTOR-MENTEE MEETINGS AT ACR 2018: TEASER

If you want to attend this activity, please stay tuned to our Social Media channels (Facebook and Twitter), EMEUNET website and emails. The call

will be launched soon. A true ‘Do Not Miss’ event!

Prof. Robert B. M. Landewé (Academic Medical Center, The Netherlands): clinical epidemiology, outcomes research, spondyloarthritis

ASAS President (2012 – 2018) ARD Editorial Board METEOR Foundation Executive Board Past-Chair of the EULAR Scientific Programme Committee OMERACT Executive Board (previous member)

17

The meetings will last approximately 60 minutes and are conceived to promote interactive discussion between mentors and mentees under an informal atmosphere. No materials or formal presentations are needed to be prepared in advance. This is a great opportunity to discuss research topics and career plans with top leading experts in your field. The number of mentees will be 4-6 for each group.

Take a look at the feedback received from previous participants of these meetings:

“Great opportunity for those starting in the field of Rheumatology. To have the chance to talk to great professors is something we should really cherish and embrace” (Valentina E. Emperiale, Spain)

“This provide us a way to get in touch with people that have a great knowledge on career path for us to take, and help us to realice about the several options we have. Mentors really dare to help us and provide the most knowledgeable advice” (Vital Da Silva, Portugal)

“I really enjoyed it. Right answers and lot of advice on how to pursue our goals. An opportunity that every EMEUNET member should take” (Luis F. Pérez, The Netherlands)

Sunday 21st of October 2018 EMEUNET MEET UP at ACR in Chicago

After the summer we are all getting back to work. This also means the annual ACR meeting is approaching. This year it will be in Chicago!

EMEUNET would like to invite you to join our

networking event on Sunday evening (October 21st 2018).

We will meet at 6.00pm at conference venue or you can join at 6.30pm at the venue

Details are provided on the website, where you can also register for this networking event

https://emeunet.eventsmart.com/events/emeunet-meet-up-at-acr-2018-in-chicago/

Looking forward to seeing you all!!

REGISTER NOW! Sunday October 21st 2018

OCTOBER 2018

NOVEMBER 2018

EDUCATIONAL EVENTS

OCTOBER - DECEMBER 2018

World Arthritis Day 2018 o When: 12 Oct 2018 o Website: http://worldarthritisday.org/

British Society for Paediatric and Adolescent Rheumatology (BSPAR) Conference o When and Where: 17 – 19 Oct 2018, Southampton, UK o Website: https://www.rheumatology.org.uk/Professional-Development/Education-Events/Conferences/Paediatric-annual-conference/Register

ACR Annual Meeting o When and Where: 19 – 24 Oct 2018, Chicago, USA o Website: https://www.rheumatology.org/Annual-Meeting

Cytokines 2018: 6th Annual Meeting of the International Cytokine & Interferon Society o When and Where: 27 Oct – 30 Oct 2018, Boston, USA o Website: https://boston.cytokinesociety.org

6th World Congress on Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD) o When and Where: 6 – 10 Nov 2018, Bangkok, Thailand o Website: http://bmjd-congress.org/

EDUCATIONAL EVENTS

OCTOBER 2018 19

EDUCATIONAL EVENTS

OCTOBER 2018 20

THE 3RD EULAR REGISTERS AND OBSERVATIONAL DRUGS MEETING

The EULAR RODS meetings have evolved into a course in which faculty and attendees are delivering and suggesting content. This course aims to provide insights into practical and methodological aspects of registers and drug observational studies, data handling and analysis, promoting and facilitating collaborative work through a series of interactive lectures, workshops and round table discussions.

The course structure and content builds on previous RODS meetings and direct feedback from participants and also brings attention to novel aspects around future applications of registers. It incorporates innovative and disruptive methodology.

In this unique 1,5 days meeting, attendees will have an opportunity to network and have a one-to-one interaction with experts in the field, as well as to present own ideas in the form of posters and oral presentations. Evaluation and feedback from participants and instructors will have many different formats (open text in the “Board of innovation” and interactive learning during lectures and workshops).

The next EULAR RODS Meeting

will take place in early October 2019 in Amsterdam, The Netherlands

Course bursaries will also be available prior to the meeting

For information, visit: https://esor.eular.org/theme/lc_eular/layout/enrol.php?id=12

MORE ON EDUCATION

21

THE EULAR ON-LINE COURSES All EULAR courses, as electronic ways of continuous medical education in rheumatology, are managed by a scientific course committee responsible for the structure and content of the courses and for ensuring regular quality control and advancement. Teams of expert authors are regularly reviewing and updating the courses to keep up with the newest developments in the field.

REGISTRATION OPEN SINCE END OF JUNE 2018 – CLOSING ON 30 NOVEMBER 2018

Course Duration Registration and More Information

13th EULAR On-line Course on Rheumatic Diseases 2 years https://www.eular.org/edu_online_course.cfm

10th EULAR On-line Course on Connective Tissue Diseases (CTD) 9 months https://www.eular.org/edu_online_course_ctd.cfm

8th EULAR On-line Course on Systemic Sclerosis (SSc) 9 months https://www.eular.org/edu_online_course_ssc.cfm

7th EULAR On-line Introductory Ultrasound Course 7 months https://www.eular.org/edu_online_course_msus.cfm

5th EULAR / PReS On-line Course in Paediatric Rheumatology 9 months https://www.eular.org/

edu_online_course_paediatric.cfm

4th EULAR On-line Course for Health Professionals 9 months https://www.eular.org/edu_online_course_hpr.cfm

NEW! EULAR On-line Course on Imaging in RMDs 1 year https://esor.eular.org/theme/lc_eular/layout/

enrol.php?id=5

The EULAR On-line Courses on Rheumatic Diseases, CTDs, SSc and US are also available as APP

THE OPINION OF TWO PARTICIPANTS:

“Ultrasonography is essential for the training of Rheumatologists and represents a key aspect of patient’s evaluation. The EULAR On-line Introductory Ultrasound Course offers theoretical basic skills on musculoskeletal ultrasound in rheumatic diseases as well as in healthy subjects. The high quality of contents as well as the experience of the Faculty are the two main reasons to join this course. Moreover, the website is straightforward and very easy to use. Upon passing the final examination, EULAR releases a certificate. This course is very useful for Rheumatologists who would like to acquire a basic theoretical knowledge on musculoskeletal ultrasound.”

“I attended the EULAR On-line Introductory Ultrasound Course. It is a well structured basic course on ultrasonography that is divided in different modules according to the different anatomical sites. Each module includes specific exercises and the final test. I found this course very interesting and it provided me with a complete overview of ultrasonography in rheumatology. I would recommend this course as to me it was overall more useful and formative compared to some different on-site courses I previously attended.”

OCTOBER 2018

The official EMEUNET calendar is now up and running on our website http://emeunet.eular.org/calendar.cfm

In 2016 EMEUNET launched a new initiative to have a shared calendar of events and deadlines. We decided to use google, as it offers the advantage of allowing synchronization with computers and mobile devices.

The calendar is fully customizable and members can decide to get notifications by email or on the mobile

If you are an apple user, we have been informed that in some cases, possibly after a system update), the synchronization is lost. If this happens, you will need to set again the synchronization at this address https://www.google.com/calendar/iphoneselect Here you can find detailed instructions on how to synchronize apple devices with the google calendar.

To follow this calendar and transfer it into your calendar manager in any device (laptop, tablet, phone), please see the instructions here.

The EMEUNET calendar has been up and running for two years, with the aim to ensure that our members would never loose a deadline or a conference! We hope you have found it useful. If you have any comment or suggestion please let us know by sending an email to [email protected]

THE EMEUNET CALENDAR

22 OCTOBER 2018

EMEUNET CALENDAR

Young investigators of EMEUNET are an integral part of all task forces and committees working on new EULAR recommendations. This is a wonderful chance for EMEUNET to increase its visibility and for you to accelerate your academic career.

The last call came in May from the EULAR Task Force on prevention and management of osteoporotic fractures

Take a look at emails from EMEUNET and find the opportunity most suitable for you!

JOIN EULAR TASK FORCES AND COMMITTEES

23

SHARE YOUR IDEAS!

Over the years EMEUNET has developed several projects covering different

topics and areas of interest. However, we appreciate any suggestions and

welcome new ideas to expand on what we currently offer to EMEUNET

members. Make your voice heard and share your ideas with us!

It is easy, just write down some lines to summarize your proposal and send it

either via email at [email protected] or through our website (

http://emeunet.eular.org/contact_us.cfm). Don’t forget to provide your contacts

so we can come back to you for additional details!

More information about EMEUNET can be found at http://emeunet.eular.org

www.facebook.com/EMEUNET

www.twitter.com/EMEUNET

http://www.linkedin.com

OCTOBER 2018

BE PART OF THE EMEUNET COMMUNITY

ACR DO NOT MISS - EMEUNET

Documents

Transcript of ACR DO NOT MISS - EMEUNET